Cogent Biosciences (COGT) Preferred Shares (2020 - 2026)

Cogent Biosciences' Preferred Shares history runs 7 years deep, the most recent figure standing at $35.6 million for Q1 2026.

• In Q1 2026, Preferred Shares fell 34.25% year-over-year to $35.6 million; the TTM figure through Mar 2026 stood at $35.6 million (down 34.25% YoY), while the FY2025 annual figure was $53.8 million, down 4.75% from the prior year.
• Preferred Shares was $35.6 million for Q1 2026 at Cogent Biosciences, down from $53.8 million in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $78.4 million in Q1 2022 to a low of $35.6 million in Q1 2026.
• Historically, Preferred Shares has averaged $59.1 million across 5 years, with a median of $60.0 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Preferred Shares changed 0.0% in 2025, then slumped 34.25% in 2026.
• A 5-year view of Preferred Shares shows it stood at $65.8 million in 2022, then declined by 8.8% to $60.0 million in 2023, then retreated by 5.86% to $56.5 million in 2024, then declined by 4.75% to $53.8 million in 2025, then sank by 33.93% to $35.6 million in 2026.
• The last three Preferred Shares figures came in at $35.6 million (Q1 2026), $53.8 million (Q4 2025), and $54.1 million (Q3 2025), per Business Quant data.